Drug Abuse:
Efforts Under Way to Determine Treatment Outcomes
T-HEHS-00-60: Published: Feb 17, 2000. Publicly Released: Feb 17, 2000.
Additional Materials:
- Full Report:
Contact:
(202) 512-7114
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
Pursuant to a congressional request, GAO discussed the Substance Abuse and Mental Health Services Administration's (SAMHSA) efforts to support an effective drug abuse treatment system, focusing on: (1) activities supported by SAMHSA's Substance Abuse Prevention and Treatment (SAPT) block grant and Knowledge Development and Application (KDA) grant funds for drug abuse treatment; (2) SAMHSA and state mechanisms for monitoring fund use; and (3) SAMHSA and state efforts to determine the effectiveness of drug abuse treatment supported with SAPT block grant funds.
GAO noted that: (1) about $581 million in SAMHSA's fiscal year (FY) 1996 grant funds was spent on drug abuse treatment activities; (2) more than $478 million was spent by the states for treatment services funded through the SAPT block grant program; (3) the 16 states GAO surveyed reported that SAPT funds supported residential and outpatient drug abuse treatment services, including detoxification and methadone maintenance; (4) for half of the states in GAO's survey, outpatient drug abuse treatment services accounted for 57 to 85 percent of their block grant expenditures; (5) all the states GAO surveyed reported providing methadone treatment services almost exclusively on an outpatient basis; (6) SAMHSA spent $25 million of the SAPT block grant for technical assistance and evaluation activities related to drug abuse treatment; (7) the remaining $78 million of SAMHSA's FY 1996 grant funds were KDA funds provided to community-based organizations, universities, and state and local government agencies to develop and disseminate information on promising drug abuse treatment practices; (8) SAMHSA monitors grantees' use of these funds through on-site reviews, reviews of independent financial audit reports, and application reviews; (9) these mechanisms are used to monitor grantees' compliance with program requirements, identify grantees' technical assistance needs, and provide grantees guidance for improving program operations; (10) the accountability system for the SAPT block grant is mostly based on a review of state expenditures designed to determine whether states comply with statutory spending requirements for use of funds, such as those that stipulate that a certain percentage of SAPT block grant funds be spent for alcohol prevention and treatment, drug prevention and treatment, and special populations; (11) SAMHSA's monitoring has not focused on the outcomes of the effectiveness of states' drug abuse treatment programs; (12) several state and SAMHSA efforts are under way to determine the effectiveness of drug abuse treatment programs using client outcome measures, such as drug use, employment, criminal activity, and living conditions; (13) nine of the 16 states have conducted such assessments, but the outcomes measured, populations assessed, methodologies used, and availability of results vary from state to state; (14) SAMHSA is funding a pilot effort to help 19 states develop and uniformly report on a core set of client outcomes; and (15) however, this effort is not likely to result in uniform state data because some of the states GAO surveyed reported that they are not collecting the requested data.
Jan 14, 2021
-
Medicaid:
Data Completeness and Accuracy Have Improved, Though Not All Standards Have Been MetGAO-21-196: Published: Jan 14, 2021. Publicly Released: Jan 14, 2021.
Jan 4, 2021
-
Medicare Severe Wound Care:
Spending Declines May Reflect Site of Care Changes; Limited Information Is Available on QualityGAO-21-92: Published: Jan 4, 2021. Publicly Released: Jan 4, 2021.
Dec 22, 2020
-
Defense Health Care:
Efforts to Ensure Beneficiaries Access Specialty Care and Receive Timely and Effective CareGAO-21-143: Published: Dec 22, 2020. Publicly Released: Dec 22, 2020.
Dec 16, 2020
-
Medicaid Long-Term Services and Supports:
Access and Quality Problems in Managed Care Demand Improved OversightGAO-21-49: Published: Nov 16, 2020. Publicly Released: Dec 16, 2020.
Dec 14, 2020
-
Drug Pricing Program:
HHS Uses Multiple Mechanisms to Help Ensure Compliance with 340B RequirementsGAO-21-107: Published: Dec 14, 2020. Publicly Released: Dec 14, 2020. -
Substance Use Disorder:
Reliable Data Needed for Substance Abuse Prevention and Treatment Block Grant ProgramGAO-21-58: Published: Dec 14, 2020. Publicly Released: Dec 14, 2020.
Dec 10, 2020
-
Indian Health Service:
Actions Needed to Improve Oversight of Provider Misconduct and Substandard PerformanceGAO-21-97: Published: Dec 10, 2020. Publicly Released: Dec 10, 2020. -
Clinical Labs:
Studies Suggest Biopsy Specimen Misidentification and Contamination Errors Are InfrequentGAO-21-59: Published: Nov 10, 2020. Publicly Released: Dec 10, 2020.
Dec 7, 2020
-
Medicaid:
CMS Needs More Information on States' Financing and Payment Arrangements to Improve OversightGAO-21-98: Published: Dec 7, 2020. Publicly Released: Dec 7, 2020.
Dec 1, 2020
-
Military Health Care:
Defense Health Agency Processes for Responding to Provider Quality and Safety ConcernsGAO-21-160R: Published: Dec 1, 2020. Publicly Released: Dec 1, 2020.
Looking for more? Browse all our products here